Skip to main
SIBN

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. has demonstrated strong financial performance with a year-over-year revenue growth of approximately 23%, totaling $46.4 million in the second quarter of 2025. The company's gross margin also improved, increasing about 80 basis points year-over-year to reach 79.8%, indicating enhanced operational efficiency. Furthermore, the positive momentum in sales productivity has led to an upward revision of the 2025 revenue estimate to $196.5 million, reflecting confidence in continued growth and market expansion.

Bears say

SI-BONE Inc faces significant challenges, as the global spine market has been hindered by pricing and procedure headwinds, resulting in slowed growth in the low-single digits. This environment creates a risk for SI-BONE, as potential declines in market share due to payer preferences for competitive products could adversely impact the company's revenue. Additionally, SI-BONE's low EV/sales/growth ratio of 0.19x, compared to its peer group's median of 0.34x, underscores concerns about its growth potential and overall financial performance.

SI-BONE Inc (SIBN) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Buy based on their latest research and market trends.

According to 6 analysts, SI-BONE Inc (SIBN) has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.